The significance of bilateral cardiomyopathy in VIP−/− mice is that this links the VIP gene to critical whole heart myosin gene overexpression, tied to abnormal function in its absence, and supports the concept of VIP therapy for cardiac disease. The gene discussed is MYH14; the disease is heart disorder.